|
IMPAD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.974600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.533000E-01 |
| Normal-vs-Stage2 |
7.195000E-01 |
| Normal-vs-Stage3 |
2.106200E-01 |
| Normal-vs-Stage4 |
1.583420E-01 |
| Stage1-vs-Stage2 |
6.835200E-01 |
| Stage1-vs-Stage3 |
4.886800E-01 |
| Stage1-vs-Stage4 |
4.592400E-01 |
| Stage2-vs-Stage3 |
4.443400E-01 |
| Stage2-vs-Stage4 |
3.819600E-01 |
| Stage3-vs-Stage4 |
8.720400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.147800E-01 |
| Normal-vs-AfricanAmerican |
6.923200E-01 |
| Normal-vs-Asian |
1.384390E-01 |
| Caucasian-vs-AfricanAmerican |
1.192400E-01 |
| Caucasian-vs-Asian |
7.514000E-01 |
| AfricanAmerican-vs-Asian |
1.260230E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.093200E-01 |
| Normal-vs-Female |
3.190000E-01 |
| Male-vs-Female |
8.015000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.927200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.440380E-01 |
| Normal-vs-Age(61-80Yrs) |
3.641600E-01 |
| Normal-vs-Age(81-100Yrs) |
7.452600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.462200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.722200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.971400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.701600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.160600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.065200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.833600E-02 |
| Classical-VS-Follicular |
3.167400E-01 |
| Classical-VS-Other |
2.408800E-01 |
| Classical-VS-Normal |
4.098200E-01 |
| Tall-VS-Follicular |
3.754200E-02 |
| Tall-VS-Other |
5.691400E-01 |
| Tall-VS-Normal |
6.276100E-02 |
| Follicular-VS-Other |
2.174800E-01 |
| Follicular-VS-Normal |
9.041600E-01 |
| Other-VS-Normal |
1.286430E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.377800E-01 |
| Normal-vs-N1 |
8.279900E-02 |
| N0-vs-N1 |
4.240600E-01 |
|
|
